Skip to main content
Clinical Trials/NCT05840263
NCT05840263
Recruiting
Not Applicable

Developing a Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer: Qualitative Phase

University of Colorado, Denver1 site in 1 country48 target enrollmentMay 31, 2023

Overview

Phase
Not Applicable
Intervention
Qualitative interview
Conditions
Metastatic Colorectal Cancer
Sponsor
University of Colorado, Denver
Enrollment
48
Locations
1
Primary Endpoint
Identify the preferences of mCRC patients' partners for intervention content
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners.

Detailed Description

The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners. The intervention is named "MIND-Together" (Mindfully Navigating Distress Together). MIND-Together will be the first mindfulness-based intervention designed to reduce mCRC couples' distress by targeting their unique psychosocial needs. The intervention is projected to be a 4-session intervention delivered by a trained therapist to individual couples facing mCRC (i.e., a patient and his/her intimate partner) via video-conference (e.g., Zoom).

Registry
clinicaltrials.gov
Start Date
May 31, 2023
End Date
December 1, 2026
Last Updated
2 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient Inclusion Criteria:
  • Provision to sign and date the consent form.
  • Stated willingness to comply with all study procedures and be available for the duration of the study.
  • Be aged \> 18 years.
  • Fluent in English language
  • Be a person (i.e., patient) diagnosed with metastatic colorectal cancer (mCRC), a partner (e.g., spouse) of someone diagnosed with mCRC, or a clinician who treats patients diagnosed with mCRC.
  • Additional patient participant inclusion criteria:
  • Has a current diagnosis of metastatic (Stage IV, recurrent) colorectal cancer
  • Has an ECOG status \<2 or otherwise deemed appropriate for study participation by a clinician
  • Is in a committed relationship with a romantic partner for \>6 months

Exclusion Criteria

  • ∙Has a serious mental illness (e.g., psychotic disorder), cognitive impairment (e.g., dementia), or medical condition (e.g., significant impaired sight/hearing) that would compromise participation

Arms & Interventions

Metastatic Colorectal Cancer Patients

We anticipate enrolling up to a total of 18 patients who have been diagnosed with metastatic colorectal cancer; 12 patients will participate in the qualitative interview, and 6 patients will participate in the cognitive interview.

Intervention: Qualitative interview

Metastatic Colorectal Cancer Patients

We anticipate enrolling up to a total of 18 patients who have been diagnosed with metastatic colorectal cancer; 12 patients will participate in the qualitative interview, and 6 patients will participate in the cognitive interview.

Intervention: Cognitive Interviews

Metastatic Colorectal Cancer Patients Partners

We anticipate enrolling up to a total of 18 partners of patients who have been diagnosed with metastatic colorectal cancer; 12 partners will participate in the qualitative interview, and 6 paartners will participate in the cognitive interview.

Intervention: Qualitative interview

Metastatic Colorectal Cancer Patients Partners

We anticipate enrolling up to a total of 18 partners of patients who have been diagnosed with metastatic colorectal cancer; 12 partners will participate in the qualitative interview, and 6 paartners will participate in the cognitive interview.

Intervention: Cognitive Interviews

Clinicians

We anticipate enrolling 12 clinicians (including physicians, nurse practitioners, physician assistants, mental health providers, other advanced practice clinicians) who treat patients with colorectal cancer at the University of Colorado to participate in qualitative interviews. We seek to enroll a variety of clinicians from advanced practiced clinical roles (physicians, nurse practitioners, and mental health providers) to capture diverse perspectives.

Intervention: Qualitative interview

Outcomes

Primary Outcomes

Identify the preferences of mCRC patients' partners for intervention content

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Identify the preferences of mCRC patients for intervention format (eg, session length)

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Identify the preferences of mCRC patients partners for intervention format

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Identify the preferences of mCRC patients for intervention content

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Identify the needs of mCRC patients' partners for intervention content

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Extract key themes to integrate into preliminary drafts

Time Frame: During the one-time qualitative interview

analyze these qualitative data to extract key themes and will integrate the findings with preliminary drafts of the MIND-Together protocol (e.g., participant handouts, therapist manual).

Identify the needs of mCRC patients for intervention content

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Identify the preferences of mCRC patients' partners for intervention format (eg, session length)

Time Frame: During the one-time qualitative interview

Completed through semi-structured qualitative interviews

Study Sites (1)

Loading locations...

Similar Trials